Skip to main content

Table 6 Incremental cost effectiveness analysis results

From: Cost effectiveness of group follow-up after structured education for type 1 diabetes: a cluster randomised controlled trial

Analysis

Intervention

Control

ICC

Group follow-up N = 216

Individual follow-up N = 221

Cost analysis

   

Total healthcare cost (€)

   

  Mean (SD)

3,551 (566)

4,337 (551)

0.016

  Incremental analysis (difference in means; intervention versus control)

−772 (95% CI, −1,415 to −128; P = 0.020)

  

Effectiveness analysis

   

 QALYs gained

   

  Mean (SD)

1.31 (0.12)

1.35 (0.12)

0.033

  Incremental analysis (difference in means; intervention versus control)

   
 

−0.04 (95% CI, −0.08 to 0.01; P = 0.052)

  
 

Cost effectiveness analysis (probability that treatment is cost effective at λ

Threshold value (λ)

  

  λ = €0

1.000

0.000

  λ = €5,000

1.000

0.000

  λ = €10,000

0.996

0.004

  λ = €15,000

0.762

0.238

  λ = €20,000

0.400

0.600

  λ = €25,000

0.204

0.796

  λ = €30,000

0.119

0.881

  λ = €35,000

0.078

0.922

  λ = €40,000

0.049

0.951

 λ = €45,000

0.033

0.967

  1. λ or threshold value of the maximum that the health system would be willing to pay per QALY gained. ICC, intra-class coefficient; QALY, quality-adjusted life year.